0001472091 2026-07-10 2026-07-10 0001472091 1 2026-07-10 2026-07-10 shares iso4217:USD shares iso4217:USD pure S-3 S-3 PDS Biotechnology Corporation false Equity Common Stock, par value $0.00033 per share true 13315823 0.823 10958922.329 0.0001381 1513.43 10958922.329 1513.43 0 0 1513.43 <table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="height: 0px; font-size: 0px;"><td style="width: 1%;"> </td><td style="width: 99%;"> </td></tr><tr style="vertical-align: top;"> <td style="padding: 0px 0pt;"> <div style="margin-bottom: 4pt;"> <span style="font-size: 10.0pt;">1</span> </div> </td> <td style="padding: 0px 5.4pt; text-align: left;"> <div style="margin-bottom: 4pt;"> <span style="font-size: 10.0pt;">(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional securities that may be offered or issued in connection with any stock dividend, stock split, recapitalization or similar transaction. <br/>(2) Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is $0.8230, which is the average of the high and low prices of the registrant's common stock, par value $0.00033 per share (“Common Stock”) on July 8, 2026, on the Nasdaq Capital Market. <br/>(3) Consists of 13,315,823 shares of Common Stock, including 2,158,274 shares of Common Stock issuable upon the exercise of certain outstanding warrants and up to 11,157,549 shares of Common Stock issuable upon conversion of a promissory note.</span> </div> </td> </tr> </table> N/A 0001472091 EX-FILING FEES N/A